A. Lindblad (Gothenburg, Sweden), N. Simmonds (London, United Kingdom)
Differences in regional pulmonary function between children with cystic fibrosis and healthy children determined by electrical impedance tomography
B. Vogt, Z. Zhao, C. Falkenberg, T. Ankermann, I. Kaak, N. Weiler, I. Frerichs (Kiel, Villingen-Schwenningen, Nebel, Amrum, Germany)
|  |
Effect of different physiotherapy devices on ventilation distribution in adults with cystic fibrosis
M. Wettstein, T. Riedel (Bern, Switzerland)
| |
Short-term effects of physiotherapy on ventilation inhomogeneity in cystic fibrosis patients with moderate to severe lung disease
A. Pfleger, M. Steinbacher, E. Weinhandl, M. Wagner, E. Eber (Graz, Austria)
|  |
High frequency chest wall oscillation (HFCWO) in the treatment of acute pulmonary exacerbation in adult cystic fibrosis (CF) patients
S. Krasovskij, E. Amelina, M. Usacheva, V. Samoylenko, N. Krilova (Moscow, Russian Federation)
| |
Regular exercise improves airway inflammation in cystic fibrosis patients
M. Laskine, V. Tardif, S. Ptaszynski, G. Leboeuf, A. Landry, A. Jeanneret-Grosjean, C. Poirier, C. Bergeron (Montreal, Canada)
| |
Exercise and sport habits in children and adolescents with cystic fibrosis
S. Karapanagiotis, A. Brivio, S. Gambazza, C. Speziali, C. Colombo (Milan, Italy)
| |
Intensity of daily activity may affect exercise capacity and peripheral muscle function in adults with cystic fibrosis
D. Savi, P. Onorati, M. Di Paolo, F. Megiorni, R. V. De Biase, E. Leggieri, F. Alatri, T. Perelli, F. Midulla, S. Quattrucci, P. Palange (Rome, Italy)
| |
Frequency and pathogenicity of rhinovirus associated pulmonary exacerbations in patients with cystic fibrosis
A. Shah, M. Connolly, L. Clasper, C. McIntyre, H. Harvala, A. Hale, P. Whitaker, P. Simmonds, D. Peckham (Leeds, Edinburgh, United Kingdom)
| |
Significant lung damage revealed at early chest computed tomography is related to subsequent pseudomonas (PsA) colonization in children with cystic fibrosis
C. F. Bortoluzzi, S. Volpi, C. D'Orazio, M. Loeve, H. A. Tiddens, B. M. Assael (Verona, Italy; Rotterdam, Netherlands)
| |
Sensitivity of N2 single breath washout (SBW) compared multiple breath washout (MBW) in adults with cystic fibrosis (CF)
B. Houltz, M. Gilljam, M. Rosberg, F. Fors, D. Persson, A. Lindblad, P. Gustafsson (Gothenburg, Skövde, Sweden)
| |
The lung clearance index correlates with markers of pulmonary deterioration in patients with cystic fibrosis
J. Grosse-Onnebrink, F. Stehling, M. Olivier, U. Mellies (Muenster, Essen, Germany)
| |
Cystic fibrosis lung disease assessed by lung clearance index
E. Hatziagorou, V. Avramidou, K. Kontouli, V. Georgopoulou, J. Tsanakas (Thessaloniki, Greece)
| |
Lung clearance index during pulmonary exacerbation in school-age children with cystic fibrosis
L. Welsh, M. Tomai, H. Tran, S. Ranganathan (Melbourne, Australia)
| |
Ventilation inhomogeneity (VI) and spirometry in response to intravenous antibiotics (IVab) in cystic fibrosis (CF)
N. Al-Khathlan, E. Gaillard, C. Beardsmore (Leicester, United Kingdom; Dammam, Saudi Arabia)
| |
Prospective follow up over 1 year with N2 multiple breath washout (MBW) in children with cystic fibrosis
A. Lindblad, M. Rosberg, B. Houltz, P. Gustafsson (Gothenburg, Skövde, Sweden)
| |
Home versus hospital treatment of acute cystic fibrosis pulmonary exacerbations – Is quality of life really better at home?
I. Sequeiros, N. Jarad (Bristol, United Kingdom)
| |
RSV hospitalization in cystic fibrosis in the Canadian registry of palivizumab (CARESS) following prophylaxis (2005-2012)
I. Mitchell, B. Paes, A. Li, K. Lanctot (Calgary, Hamilton, Toronto, Canada)
| |
Prospective audit examing the resting energy expenditure (REE) of paediatric patients with CF
M. O'Reilly, C. Dempsey, D. Moran, M. Morgan, D. Slattery, F. Healy (Dublin, Ireland)
| |